Friday, February 28, 2020
Home Events Get Ready for Allergan's New DTC Juvedérm Lips Campaign

Get Ready for Allergan’s New DTC Juvedérm Lips Campaign

New York City-based facial plastic surgeon Dara Liotta, MD, reality TV personality Audrina Patridge, and celebrity makeup artist Kelsey Deenihan will share how and why they choose Juvedérm as their lip filler brand of choice.

Allergan is launching its new direct-to-consumer campaign for Juvedérm lips with ads and creative deploying across TV, social media, and digital advertising.

As part of the new campaign, New York City-based facial plastic surgeon Dara Liotta, MD, reality television personality Audrina Patridge, and celebrity makeup artist Kelsey Deenihan will share how and why they choose Juvedérm as their lip filler brand of choice.

Created by Shespoke and inspired by the bold shades of Juvedérm, Deenihan helped curate a limited-edition lip kit featuring three shades designed to accentuate one’s pout.

Customers can engage with the brand here and enter to win the limited-edition lipstick kit and other prizes by registering for Brilliant Distinctions and getting treated with Juvedérm Ultra XC Juvedérm or Volbella XC. One grand prize winner will receive $1,000 in Brilliant Distinctions® points and the SHESPOKE limited edition lipstick kit, while 250 additional winners will receive $100 in Brilliant Distinctions® points and the limited-edition lipstick kit.

- Advertisment -

Most Popular

BioScience launches new range of monophasic dermal fillers

Aesthetic product manufacturer BioScience GmbH has launched HYAProf, a new injectable line which combines monodensified and polydensified dermal fillers.

Aesthetics Biomedical Announces Molly Sims as SoME™ Skincare Brand Ambassador

The innovators at Aesthetics Biomedical (ABM), a leading aesthetics product development corporation, proudly welcome Molly Sims as Brand Ambassador for SoME™ Skincare That's All...

FDA approves Cynosure’s Potenza radiofrequency microneedling device

Medical aesthetics company Cynosure has secured approval from the US Food and Drug Administration (FDA) for its Potenza radiofrequency (RF) microneedling device.

Business News: Lilly, Dermira Acquisition Complete

The acquisition expands Lilly's immunology pipeline with lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 that is being evaluated for...

Recent Comments